LEIi020-A

Not yet reviewed by Australian Stem Cell Registry

1049ips2

Details

Tissue & Disease as reported

Biopsy Location
Ontology ID: fma7163
Label: Skin
Definition: Nonparenchymatous organ that consists of the epidermis, dermis and sets of hair and nails and which surrounds the entire body. Subdivisions of the skin surround various body parts; as a whole, the skin constitutes the external layer of the body. Examples: There is only one skin.
Tissue for derived iPSC
Disease as reported (Donor)
usher syndrome type 1b

Genetic Information

Genotype Locus
MYO7A
Polymorphism
Homozygous: NM_000260.3:c.496del(NP_000251.3:p.Glu166Argfs*5)

Line Custodianship

Cell Line Maintainer

McLenachan

Affiliated Institutions
  • Lions Eye Institute, Nedlands, Australia
View all cell lines from this group

Cell Line Producer

Lions Eye Institute

Affiliated Institutions
  • Lions Eye Institute, Nedlands, Australia

Source

Donor Derived

Age: 35-39

Biological Sex: Male

Disease: MONDO:0700087
Label: Usher syndrome type 1B
Definition: Usher syndrome in which the cause of the disease is a mutation in the MYO7A gene

Derivation Details

Induced Pluripotent Cell Derivation Details

Source Cell Type: CL:0000057
Label: fibroblast
Definition: A connective tissue cell which secretes an extracellular matrix rich in collagen and other macromolecules. Flattened and irregular in outline with branching processes; appear fusiform or spindle-shaped.

Source Cell Origin: UBERON:0002067
Label: dermis
Definition: The dermis is a layer of skin between the epidermis (with which it makes up the skin) and subcutaneous tissues, and is composed of two layers, the papillary and reticular dermis[WP].

Derivation Year: 2020

Reprogramming Method

Vector Type: Not integrated

Vector: Episomal

Kit: [kit] Episomal iPSC Reprogramming Plasmids

Detected: No

Ethics

Ethics Number: RA/4/1/7916

Institution Human Research Ethics Council: University of Western Australia Human Research Ethics Committee

Approval Date: To be verified

Modifications

No genomic modifications available for this line.

Quality Assurance

Genomic Characterisation

Passage Number: 15

Karyotype: arr(1-22)x2,(XY)x1,dup(8)(p21.2)

Karyotype Method: Molecular karyotyping by SNP array

Summary: Molecular karyotyping by SNP array (Illumina Infinium Human CytoSNP-12; resolution 500 kb).

STR analysis Results:

Performed but not available.

Microbiology and Virology Screening

Disease Result
Mycoplasma Negative

Characterisation of Undifferentiated Cells

Marker Method
POU5F1 (OCT-4) Immunostaining
NANOG Immunostaining
SOX2 Immunostaining
SSEA-4 Immunostaining
MYC RT-PCR
NANOG RT-PCR
POU5F1 (OCT-4) RT-PCR
SOX2 RT-PCR

Scorecard Results

Undifferentiated Cells

No available data for this cell line.

Pluripotency

No available data for this cell line.

Pluripotency Characterisation

Endoderm

In vitro spontaneous differentiation

Assessed by: RT-PCR

Markers: CDX2;LEFTY1;PDX1

Mesoderm

In vitro spontaneous differentiation

Assessed by: RT-PCR

Markers: HAND1;TBX6;TBXT

Ectoderm

In vitro spontaneous differentiation

Assessed by: RT-PCR

Markers: NEUN;PAX6;TUBB3

Growth Characteristics

Culture Medium and Growth Conditions

CO2 concentration: 5%

O2 concentration: 21%

Medium Items:

  • Base Medium: TeSR-E8 - STEMCELL Technologies
  • Base Coat: Geltrex

Passage Method: Enzymatically